|
US2021085493A1
|
|
Breathable Residual-Limb Socket System
|
|
US2021086984A1
|
|
Device and Method for Preventing Immediate Access to an Object
|
|
US2020272254A1
|
|
Computer Pointing Device
|
|
US2020256632A1
|
|
Trigger Actuator
|
|
US2020158256A1
|
|
Clamp with State Signal
|
|
CA3115075A1
|
|
Spak kinase inhibitors as neuroprotective agents
|
|
WO2019241141A1
|
|
Method for treating myocardial reperfusion injury using an inhibitor of the cyclic nucleotide phosphodiesterase pde1
|
|
WO2019226612A1
|
|
Compositions and methods for treating rsv-infections
|
|
US2020071747A1
|
|
Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium
|
|
EP3781066A1
|
|
Methods and kits for optimization of neurosurgical intervention site
|
|
EP3758648A1
|
|
Devices and systems for treatment of urinary incontinence, and methods of making and using same
|
|
WO2019157150A1
|
|
Methods for precision therapeutic targeting of human cancer cell motility and kits thereof
|
|
AU2019207724A1
|
|
Sampling catheter with articulating tip
|
|
WO2019075465A1
|
|
Compositions and methods of interferon alpha binding proteins
|
|
US2020276293A1
|
|
Bacterial protein compositions and uses thereof
|
|
US2019038484A1
|
|
Wheelchair System with Motion Sensors and Neural Stimulation
|
|
US2018214450A1
|
|
Treatment of kidney diseases associated with elevated AVP
|
|
WO2018081624A1
|
|
Microrna in t cell activation
|
|
US2018044409A1
|
|
Antibody-mediated transduction of heat shock proteins into living cells
|
|
CN108434138A
|
|
For treating ethyl hydroxychloroquine is gone with inflammation relevant disease
|
